Board of Trustees

Kathleen G. Beavis, MD, Secretary

Kathleen G. Beavis, MD, President

Dr. Beavis is a Professor in the Department of Pathology at the University of Chicago, where she is the Vice Chair for Clinical Academic Affairs. She began her term as a Trustee of the ABPath on January 1, 2019, and her current responsibilities include Chairperson, Test Development & Advisory Committee for Medical Microbiology; Chairperson, Test Development and Advisory Committee for Management & Informatics; Chairperson, Credentials Committee; and Chairperson, Competency-Based Assessment (CBA) Task Force. She earned her A.B. in Philosophy from Harvard College and was a Rotary International Graduate Fellow for studies in theology and philosophy of science at Eberhard Karls Universitaet in Tuebingen, Germany. Dr. Beavis received her M.D. degree from the University of Pennsylvania School of Medicine. She completed an internship in Anatomic Pathology at Massachusetts General Hospital and residency in Anatomic and Clinical Pathology and fellowship in Microbiology at the Cleveland Clinic Foundation. She is board certified in Clinical Pathology and is participating in the Continuing Certification Program.

Dr. Beavis has served and held leadership positions in several national and international professional organizations. She has received both the Lifetime Achievement Award and the Distinguished Patient Care Award from the CAP. Dr. Beavis has a strong interest in Global Health and is the Director of the Global and Public Health Track for University of Chicago undergraduates.

Mark K. Fung, MD, PhD, Vice President

Dr. Fung is Professor and Director of the Cell Therapy Laboratory and Point of Care Testing in the Department of Pathology and Laboratory Medicine at the University of Vermont. He has been a Trustee of the ABPath since 2021 and his current responsibilities include Chairperson, Test Development & Advisory Committee for Blood Banking/Transfusion Medicine; Chairperson, Practice and Training Survey Committee; and Chairperson, Strategic Planning Committee.

Dr. Fung earned his B.A. in Biology from Wesleyan University. He received both his M.D. degree and Ph.D. degree in Cellular and Molecular Pathology from the University of Alabama-Birmingham. He completed two years of residency in Anatomic and Clinical Pathology at Washington University in St Louis before transferring to the University of Pittsburgh to complete his residency training and fellowship training in Blood Banking/Transfusion Medicine. Dr. Fung is board certified in Clinical Pathology and Blood Banking/Transfusion Medicine and is participating in the Continuing Certification Program.

Dr. Fung has leadership roles in other organizations to include the Association for the Advancement of Blood and Biotherapies (AABB), College of American Pathologists (CAP), Vermont Medical Society and the Project Santa Fe Foundation/Clinical Lab 2.0 Initiative. He is on the editorial board for Transfusion, Transfusion Medicine Reviews, and Population Health Management, and was editor-in-chief for the 18th and 19th editions of the AABB Technical Manual. Dr. Fung received the 2023 Lifetime Achievement Award from the CAP.

Jennifer Laudadio, MD, Treasurer

Dr. Jennifer Laudadio is Professor and Chair in the Department of Pathology at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, AR. She is a recipient of the Aubrey J. Hough Jr, MD, Distinguished Chair in Pathology. She serves as Director of the Laboratory and Pathology Service Line for UAMS Health. Dr. Laudadio is a member of the ACGME Pathology Review Committee and also served as a Pathology Residency Program Director. Dr. Laudadio began her term as a Trustee in January 2023. Her current responsibilities include Chairperson, Finance and Audit Committee; Chairperson, Test Development & Advisory Committee for Molecular Genetics; and Vice Chairperson, Test Development & Advisory Committee for ABPath CertLink Clinical Pathology. Dr. Laudadio earned a B.A. in Chemistry from Wake Forest University and her M.D. from the Medical College of Georgia. She completed an Anatomic and Clinical Pathology Residency at the Medical University of South Carolina and Molecular Genetic Pathology Fellowship at Oregon Health and Sciences University. Dr. Laudadio is board certified in Anatomic and Clinical Pathology and Molecular Genetics and is participating in the Continuing Certification Program.

She is a Molecular Pathology Section Editor for Archives of Pathology and Laboratory Medicine and has served on numerous committees for the College of American Pathologists and the Association for Molecular Pathology. She is a former President of the College of American Pathologists Foundation and served ex-officio on the CAP Board of Governors.

Matthew J. Wasco, MD, Secretary

Dr. Matthew Wasco is an anatomic and clinical pathologist with IHA Pathology and Laboratory Management, serving Trinity Health Ann Arbor Hospital and multiple associated facilities in Ann Arbor, MI, and other parts of southeast Michigan. Since joining IHA pathology in 2009, Dr. Wasco has been a laboratory director for multiple facilities and a section leader for various parts of the clinical laboratory. Dr. Wasco was appointed a Trustee in 2021. His current responsibilities include Chairperson, Nominating Committee; Vice Chairperson, Continuing Certification Committee; and Trustee Liaison to the Neuropathology Test Development and Advisory Committee. Dr. Wasco earned a B.A. in Chemistry at Carleton College, graduated medical school and a post-sophomore fellowship in pathology at the University of Massachusetts, and completed AP/CP pathology residency and a fellowship in Genitourinary Surgical Pathology at the University of Michigan. He is board certified in Anatomic and Clinical Pathology and is participating in the Continuing Certification Program.

Dr. Wasco has served on committees for the American Society of Clinical Pathology and the United States and Canadian Academy of Pathology, as well as local hospital administrative responsibilities and is the current president of the Michigan Society of Pathologists. He had also previously served on ABPath’s Continuing Certification Advisory Committee.

Mohiedean Ghofrani, MD, MBA, Immediate Past President

Dr. Ghofrani is System Medical Director for Laboratory Services and Director of Cytopathology and Women’s Health at PeaceHealth Southwest Medical Center in Vancouver, Washington. He has been a Trustee of the ABPath since 2017 and his current responsibilities include Chairperson, Test Development and Advisory Committee for Anatomic Pathology; Chairperson, Bylaws and Governance Committee; and Vice Chairperson, Committee on Examinations. He earned his medical degree in Tehran, followed by a residency in Anatomic and Clinical Pathology and fellowship in Cytopathology at Yale University. Dr. Ghofrani has subspecialty training and expertise in breast and gynecologic pathology. He holds a Master of Business Administration with a focus on healthcare from George Washington University and has a special interest in clinical informatics. He is board certified in Anatomic and Clinical Pathology, Cytopathology, and Clinical Informatics, and is participating in the Continuing Certification Program.

Dr. Ghofrani is active in state, national and international pathology societies, and has served as President of the Washington State Society of Pathologists, President of the Oregon Pathologists Association, Chair of the American Society of Cytopathology Budget and Finance Committee, and Vice-Chair of the College of American Pathologists Cytopathology Committee.

James R. Cook, MD, PhD

Dr. James Cook is the Hematopathology Section Head at Cleveland Clinic in Cleveland, Ohio, and Professor of Pathology at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. Dr. Cook began his term as a Trustee in January 2023. His current responsibilities include Chairperson, Test Development and Advisory Committee for Hematopathology; and Chairperson, Ethics and Professionalism Committee. Dr. Cook is a graduate of the MD/PhD program at Washington University in St. Louis. He completed his residency training at Barnes-Jewish Hospital in St. Louis, Missouri and fellowship training in Hematopathology at the University of Pittsburgh. Dr. Cook is board certified in Anatomic Pathology and Hematopathology and is participating in the Continuing Certification Program.

Dr. Cook has authored more than 150 peer-reviewed publications in hematopathology and has participated in numerous national and international post-graduate medical education activities. He has served on multiple committees for the United States and Canadian Academy of Pathology and the Association for Molecular Pathology and is a recent President of the Society for Hematopathology.

Jason A. Jarzembowski, MD, PhD

Dr. Jarzembowski is Vice Chair for Pediatric Pathology and Professor of Pathology at the Medical College of Wisconsin and Chief Executive Officer of Children’s Specialty Group. He began his term as a Trustee of the ABPath on January 1, 2026. His current responsibilities include serving as Vice Chairperson, Test Development and Advisory Committee for Management & Informatics. He earned his doctorate in Molecular and Cellular Pathology at the University of Wisconsin–Madison and his medical degree with research honors at the Medical College of Wisconsin. He completed his residency in anatomic and clinical pathology at the University of Michigan, followed by a fellowship in pediatric pathology at St. Louis Children’s Hospital and Washington University in St. Louis. Dr. Jarzembowski is board certified in Anatomic and Clinical Pathology and Pediatric Pathology and is participating in the Continuing Certification Program.

Dr. Jarzembowski is Associate Editor of the journals Pediatric and Developmental Pathology and American Journal of Clinical Pathology. He also serves on the editorial board of the Archives of Pathology & Laboratory Medicine and co-authored the College of American Pathologists cancer reporting protocols for neuroblastoma. He chaired the Children’s Oncology Group’s Pathology Committee from 2016-2026 and was an expert editor for the inaugural WHO Classification of Tumours: Paediatric Tumours. He has previously served on the board of directors for the Society for Pediatric Pathology and chaired both its Research and its Informatics and Communication Committees.

Julie D. Kingery, MD

Dr. Kingery is Clinical Associate Professor, Vice Chair of Clinical Pathology, and Laboratory Director in the Department of Pathology, Immunology and Laboratory Medicine at the University of Florida College of Medicine. Prior to her position at the University of Florida, she was a clinical pathologist and Associate Medical Director of a high-volume reference laboratory for Kaiser Permanente in Northern California. Dr. Kingery began her term as a Trustee in January 2023. Her current responsibilities include Chairperson, Test Development and Advisory Committee for ABPath CertLink Clinical Pathology; and Trustee Liaison, Test Development and Advisory Committee for Chemical Pathology.

Dr. Kingery earned a B.S. in Biology at Pacific Lutheran University in Tacoma, WA; graduated medical school and completed residency training at Loma Linda University School of Medicine. Following residency, Dr. Kingery completed a molecular genetic pathology fellowship at the Oregon Health & Sciences University and a medical microbiology fellowship at The Johns Hopkins University School of Medicine. Dr. Kingery is board certified in Clinical Pathology, Medical Microbiology, and Molecular Genetic Pathology and is participating in the Continuing Certification Program.

Dr. Kingery has been involved in national professional societies throughout her career serving on committees for the College of American Pathologists and the American Society of Clinical Pathology. She also served on the ABPath’s Continuing Certification Advisory Committee..

Dylan V. Miller, MD

Dr. Miller is a Professor of Pathology at the University of Utah School of Medicine and the Director of IHC and Electron Microscopy at Intermountain Central Laboratory, which serves Intermountain Healthcare’s multistate hospital system. He practices with a private group at Intermountain Medical Center in Salt Lake City. Dr. Miller began his term as a Trustee of the ABPath on January 1, 2025. His current responsibilities include Chairperson, Diplomate Advisory Committee; Vice Chairperson, Joint Policy Committee for Dermatopathology; Vice Chairperson of the Dermatopathology Test Development and Advisory Committee; and Vice Chairperson, Test Development and Advisory Committee for ABPath CertLink Anatomic Pathology. Dr. Miller earned his MD from the University of Utah School of Medicine and completed his residency and surgical pathology fellowship at the Mayo Clinic in Rochester, MN. Dr. Miller is board certified in Anatomic and Clinical Pathology and is participating in the Continuing Certification Program.

Dr. Miller is widely published, particularly in cardiovascular, transplant, and autopsy pathology. He has authored numerous book chapters and co-edited textbooks on cardiovascular and hospital autopsy pathology. He currently serves as President of the Utah Society for Pathology, Chair of the CAP Immunohistochemistry Committee, and previously chaired the CAP Autopsy Committee. He is also the Vice President of the Society for Cardiovascular Pathology and on the Leadership Advisory Forum of the International Society for Heart and Lung Transplantation.

Ritu Nayar, MD

Dr. Nayar is Professor and Executive Vice Chair of Pathology at Northwestern University, Chicago. She has been a Trustee of the ABPath since 2016 and her current responsibilities include Chairperson, Test Development and Advisory Committee for Cytopathology; Chairperson, Test Development and Advisory Committee for ABPath CertLink Anatomic Pathology; and Chairperson, Continuing Certification Committee. Dr Nayar received her MBBS and MD (Pathology) degrees from Delhi University, completed AP/CP residency and a surgical pathology fellowship at George Washington University and a cytopathology fellowship at the University of Rochester. She is ABPath certified in Anatomic and Clinical Pathology and Cytopathology and is participating in the Continuing Certification Program.

Dr Nayar has been an active leader in organized Pathology since she was a resident, having chaired several committees in a number of professional organizations; including serving as President of the American Society of Cytopathology and on the Executive Council of the International Academy of Cytology. She has published extensively and served as editor of the Bethesda System for Reporting Cervical Cytology, which was the model for development of other standardized terminology systems in cytopathology. Dr Nayar received the 2019 Lifetime Achievement Award from the College of American Pathologists, the 2018 Papanicolaou Award from the American Society of Cytopathology, the 2018 Maurice Goldblatt Award from the International Academy of Cytology, and the 2023 Lifetime Achievement Award from the Papanicolaou Society of Cytopathology.

Javarro Russell, PhD

Dr. Javarro Russell serves as the Public Member, Board of Trustees for the American Board of Pathology and is the Senior Director for Admissions & Testing Services at the Association of American Medical Colleges (AAMC). Dr. Russell began his term as the Public Member Trustee of the ABPath on January 1, 2024. His current responsibilities include serving as Chairperson, Exam Construction Task Force. In his AAMC leadership role, he is responsible for the strategic direction of services critical to medical education, including the MCAT, the PREview exam, and the American Medical College Application Service (AMCAS). Dr. Russell is a dynamic leader and subject matter expert specializing in educational measurement, assessment design, and business success strategies.

Prior to the AAMC, he gained extensive experience in high-stakes testing, serving in leadership roles at the National Board of Medical Examiners and the Educational Testing Service. He is focused on identifying solutions for assessing critical student learning outcomes such as critical thinking and collaborative problem-solving.

Dr. Russell holds a Ph.D. in Assessment and Measurement from James Madison University and is a proud alumnus of Norfolk State University. He brings his expertise in accountability and the use of assessment data to the ABPath Board, ensuring standards remain robust and focused on public trust.

Barbara A. Sampson, MD, PhD

Dr. Barbara Sampson is the forensic pathologist for the Roberts Program of Boston Children’s Hospital. She also consults in forensic and cardiovascular pathology. Previously, she served as Vice Chair of Pathology for Strategic Initiatives and Academic Affairs and Professor in the Department of Pathology, Molecular and Cell Based Medicine at the Icahn School of Medicine at Mount Sinai. She was the Chief Medical Examiner of the City of New York from 2013-2020 and was the first woman appointed to lead this. She has been a Trustee of the ABPath since 2017, and her current responsibilities include serving as Chairperson, Test Development and Advisory Committee for Forensic Pathology. She earned her Bachelor’s degree at Princeton, her Ph.D. in Molecular Biology at Rockefeller University, her M.D. at Weill Cornell, and did her residency at Brigham and Women’s Hospital. Dr. Sampson is board certified in Anatomic and Clinical Pathology and Forensic Pathology and is participating in the Continuing Certification Program.

She served as President of the Society of Cardiovascular Pathology and is a member of the National Association of Medical Examiners, the United States and Canadian Academy of Pathology, and the American Academy of Forensic Sciences. Dr. Sampson has published widely on forensic pathology, cardiovascular pathology, and microbiology, including 57 articles and 7 book chapters, and serves as an Assistant Editor of the journal Cardiovascular Pathology. She is the recipient of the Young Investigator Award from the Society of Cardiovascular Pathology and the E.R. Squibb and Sons Senior Thesis Prize for Contribution to Scientific Research.